As we reflect on the past year, we are both proud and inspired by the progress we have achieved together for the Parkinson’s community in British Columbia.
2019 Annual Report
read more
Home /
LRRK2 Activity in Health and Disease: Elevated ROS Levels in Inflamed, LRRK2 Mutant Brain
Inflammation and genetics are two key factors linked to Parkinson’s disease, but neither alone may trigger the disease. Dr. Michael Schlossmacher, from the University of Ottawa Research Institute, is studying the interaction between inflammation and a gene mutation, LRRK2, found in people with PD.
In Memoriam of Paddi Wood
Dear friends of the Parkinson’s community: It is with deep regret that we share with you today that our friend, Paddi Wood, passed away suddenly this weekend. The news brought shock to the office as she was in great spirits last week when Jean Blake, our CEO, had...
“Feeling Courage Despite Trembling” by Steven Ward (poem)
Express Yourself is a 10-part writing workshop for people with Parkinson's and carepartners, held in the winter of 2019. Led by Rebecca Gifford, this workshop guided new and experienced writers through writing and mindfulness exercises, as well as group meditation to...
New updates on Parkinson’s drug shortages in Canada
SINEMET® (levodopa/carbidopa) Merck Canada Inc., distributor of SINEMET® (levodopa/carbidopa) in Canada, released a statement on October 30th, 2018 noting that there are global manufacturing delays in the production and resupply of these products. There is...
We’re looking for a Support Group Facilitator in Cranbrook!
Parkinson Society British Columbia is actively recruiting a volunteer Support Group Facilitator to assist in maintaining and strengthening the Parkinson’s community in Cranbrook. Established in 1969, Parkinson Society British Columbia (PSBC) serves to empower the...
We are recruiting community leaders for the Step by Step walking program!
Starting Saturday April 11, Parkinson Society BC is bringing back Step by Step for its sixth consecutive year! Step by Step is a free 12-week walking program aimed at incrementally improving the number of average daily steps an individual takes. This program gives...
Viewpoints: Winter 2019
In the Winter 2019 issue of Viewpoints, Parkinson Society British Columbia (PSBC) shares tips for managing holiday stress for people with Parkinson’s disease (PD) and their carepartners. This issue also highlights the release of the updated Canadian Guidelines for...
Movapo (Apomorphine) now available under the Limited Drug Coverage Program in BC
As of November 26, 2019, apomorphine hydrochloride, sold under the brand name Movapo, has been made available as a part of BC PharmaCare’s Limited Drug Coverage Program under Special Authority. Special Authority grants coverage to a...